Results 231 to 240 of about 1,021,856 (349)

Editorial: Surgical treatment and perioperative organ protection for coronary heart disease and comorbid chronic diseases. [PDF]

Front Med (Lausanne)
Zhang K, Zhang C, Yuan Y, Cao J, Wang J.
europepmc   +1 more source

Relationship of periodontal infection to serum antibody levels to periodontopathic bacteria and inflammatory markers in periodontitis patients with coronary heart disease

, 2007
Kazuhisa Yamazaki, Takuya Honda, Hisanori Domon, Takafumi Okui, Keiko Kajita, R. Amanuma, C. Kudoh, Shogo Takashiba, Susumu Kokeguchi, Fusanori Nishimura, Makoto Kodama, Yoshiyasu Aizawa, Hitomi Oda   +12 more
openalex   +1 more source

Safety and pharmacokinetics of a novel potent GABA analogue crisugabalin in Chinese subjects with various degrees of renal impairment

British Journal of Clinical Pharmacology, EarlyView.
Aims Crisugabalin is a novel calcium channel α2δ subunit ligand and a highly selective oral gamma‐aminobutyric acid (GABA) analogue developed for the treatment of diabetic peripheral neuropathic pain (DPNP) and postherpetic neuralgia (PHN). This study investigated pharmacokinetic properties and safety of crisugabalin in subjects with renal impairment ...
Shibeilei Lin, Ye Wang, Chao Hu, Yanhuan Feng, Xi Tang, Ping Fu, Jia Miao   +6 more
wiley   +1 more source

Human vs. artificial intelligence: Physicians outperform ChatGPT in real‐world pharmacotherapy counselling

British Journal of Clinical Pharmacology, EarlyView.
Aims To assess the utility of the artificial intelligence (AI) chatbot ChatGPT (openly available version 3.5) in responding to real‐world pharmacotherapeutic queries from healthcare professionals. Methods Three independent and blinded evaluators with different levels of medical expertise and professional experience (beginner, advanced, and expert ...
Benjamin Krichevsky, Stefan Engeli, Stefanie M. Bode‐Böger, Felix Koop, Martin Schulze Westhoff, Sebastian Schröder, Carsten Schumacher, Thorben Pape, Dirk O. Stichtenoth, Johannes Heck   +9 more
wiley   +1 more source

Associations between multimorbidity and unintentional falls among older adults with coronary heart disease. [PDF]

Front Public Health
Qi X, Yao X, Liu S, Fan L, Wu X, Qi X, Shi F, Wang S, Xue F.   +8 more
europepmc   +1 more source

Virtual healthcare compared to hospital care for acute and post‐acute illness in adults: A systematic review and meta‐analysis of randomized controlled trials

British Journal of Clinical Pharmacology, EarlyView.
Aim To evaluate the clinical effectiveness, cost‐effectiveness, quality of life (QoL) and patient/caregiver satisfaction associated with VWs/HaH vs. traditional inpatient care in adults with acute or post‐acute illness. Methods We conducted a systematic review and meta‐analysis of randomized controlled trials (RCTs), following PRISMA 2020 guidelines ...
Rana A. Malhis, Stuart E. Bond, Ahmed A. Sadeq, Rani Shatnawi, Barbara R. Conway, Syed Shahzad Hasan, Mamoon A. Aldeyab   +6 more
wiley   +1 more source

Plasma Protein Profile Associated With a Family History of Early-Onset Coronary Heart Disease. [PDF]

Circ Genom Precis Med
Wahrenberg A, Lind L, Åberg N, Häbel H, Ström M, Mälarstig A, Magnusson PKE, Kuja-Halkola R, Bergström G, Engström G, Hagström E, Jernberg T, Söderberg S, Östgren CJ, Svensson P.   +14 more
europepmc   +1 more source

THE CONDITION OF THE CORONARY ARTERIES IN PATIENTS WITH CORONARY HEART DISEASE AND DIABETES MELLITUS TYPE 2 DEPENDING ON THE TYPES OF DYSLIPIDEMIAS

, 2017
A. О. Sypalo, Павло Григорович Кравчун, O. I. Kadykova, І.О. Iniutochkina   +3 more
openalex   +2 more sources

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, EarlyView.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo, Iain Frater, Rebecca Kuruvilla, Stefanie Lip, Hannah O'Neill, Kerry Burke, Vicky Chaplin, Alexander S. F. Doney, Salim Elyas, Nicholas Greaves, Sophie Harding, David Hargroves, Judith Hayward, Dyfrig A. Hughes, Tom A. T. Hughes, Sree Kondapally, Patrick Mok, Aaron Peace, Imran Rafi, Simon Ray, Vicky Stinton, Luigi Venetucci, Munir Pirmohamed   +22 more
wiley   +1 more source

Coronary heart disease and type 2 diabetes metabolomic signatures in the Middle East. [PDF]

Front Endocrinol (Lausanne)
Elshrif M, Isufaj K, El-Menyar A, Ullah E, Beotra A, Al-Maadheed M, Mohamed-Ali V, Saad M, Al Suwaidi J.   +8 more
europepmc   +1 more source